Optimizing use of SGLT2 inhibitors and other evidence-based therapies to improve outcomes in patients with type 2 diabetes and chronic kidney disease: An opportunity for pharmacists
Gespeichert in:
| Veröffentlicht in: | American journal of health-system pharmacy 2022-01, Vol.79 (1), p.e65-e70 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e70 |
|---|---|
| container_issue | 1 |
| container_start_page | e65 |
| container_title | American journal of health-system pharmacy |
| container_volume | 79 |
| creator | Neumiller, Joshua J Shubrook, Jay H Manley, Tom Alicic, Radica Z Tuttle, Katherine R |
| description | |
| doi_str_mv | 10.1093/ajhp/zxab271 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2546975604</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/ajhp/zxab271</oup_id><sourcerecordid>2546975604</sourcerecordid><originalsourceid>FETCH-LOGICAL-c323t-8a86050e0136b9a07ffb5705c29e055b794610dede80afc69e6a72e4545ac69d3</originalsourceid><addsrcrecordid>eNp9kU1v1DAQhiMEoqVw44zmBoeGTpw4H9yqihaklXqgnCPHmZApG9vYTmH7v_h_eLULR07z9eiRRm-WvS7wfYFdeaHuZ3fx-EsNoimeZKeFLGUuOsSnqcemywW24iR7EcI9YiFarJ9nJ2VVtLIV9Wn2-9ZFXviRzTdYA4Gd4MvN5k4Am5kHjtYHUGYEG2fyQA88ktGUDyrQCPudckwBogVenLcPybBGbZe0YwNORSYTA_zkOEPcOQIBI6uBIh28evbWsIbvPBrapVugpP4Alwasc9bH1XDcwWQ9uFn5RWkOMbzMnk1qG-jVsZ5lX68_3l19yje3N5-vLje5LkUZ81a1NUokLMp66BQ20zTIBqUWHaGUQ9NVdYEjjdSimnTdUa0aQZWspErTWJ5l7w7e9NqPlULsFw6atltlyK6hF7Kqu0bWWCX0_IBqb0PwNPXO86L8ri-w3wfV74Pqj0El_M3RvA4Ljf_gv8kk4O0BsKv7v-oPi9WhuA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2546975604</pqid></control><display><type>article</type><title>Optimizing use of SGLT2 inhibitors and other evidence-based therapies to improve outcomes in patients with type 2 diabetes and chronic kidney disease: An opportunity for pharmacists</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Neumiller, Joshua J ; Shubrook, Jay H ; Manley, Tom ; Alicic, Radica Z ; Tuttle, Katherine R</creator><creatorcontrib>Neumiller, Joshua J ; Shubrook, Jay H ; Manley, Tom ; Alicic, Radica Z ; Tuttle, Katherine R</creatorcontrib><identifier>ISSN: 1079-2082</identifier><identifier>EISSN: 1535-2900</identifier><identifier>DOI: 10.1093/ajhp/zxab271</identifier><identifier>PMID: 34185826</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Diabetes Mellitus, Type 2 - drug therapy ; Diabetes Mellitus, Type 2 - epidemiology ; Humans ; Pharmacists ; Renal Insufficiency, Chronic - drug therapy ; Renal Insufficiency, Chronic - epidemiology ; Sodium-Glucose Transporter 2 Inhibitors</subject><ispartof>American journal of health-system pharmacy, 2022-01, Vol.79 (1), p.e65-e70</ispartof><rights>American Society of Health-System Pharmacists 2021. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com . 2021</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c323t-8a86050e0136b9a07ffb5705c29e055b794610dede80afc69e6a72e4545ac69d3</citedby><cites>FETCH-LOGICAL-c323t-8a86050e0136b9a07ffb5705c29e055b794610dede80afc69e6a72e4545ac69d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,27931,27932</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34185826$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Neumiller, Joshua J</creatorcontrib><creatorcontrib>Shubrook, Jay H</creatorcontrib><creatorcontrib>Manley, Tom</creatorcontrib><creatorcontrib>Alicic, Radica Z</creatorcontrib><creatorcontrib>Tuttle, Katherine R</creatorcontrib><title>Optimizing use of SGLT2 inhibitors and other evidence-based therapies to improve outcomes in patients with type 2 diabetes and chronic kidney disease: An opportunity for pharmacists</title><title>American journal of health-system pharmacy</title><addtitle>Am J Health Syst Pharm</addtitle><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Diabetes Mellitus, Type 2 - epidemiology</subject><subject>Humans</subject><subject>Pharmacists</subject><subject>Renal Insufficiency, Chronic - drug therapy</subject><subject>Renal Insufficiency, Chronic - epidemiology</subject><subject>Sodium-Glucose Transporter 2 Inhibitors</subject><issn>1079-2082</issn><issn>1535-2900</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1v1DAQhiMEoqVw44zmBoeGTpw4H9yqihaklXqgnCPHmZApG9vYTmH7v_h_eLULR07z9eiRRm-WvS7wfYFdeaHuZ3fx-EsNoimeZKeFLGUuOsSnqcemywW24iR7EcI9YiFarJ9nJ2VVtLIV9Wn2-9ZFXviRzTdYA4Gd4MvN5k4Am5kHjtYHUGYEG2fyQA88ktGUDyrQCPudckwBogVenLcPybBGbZe0YwNORSYTA_zkOEPcOQIBI6uBIh28evbWsIbvPBrapVugpP4Alwasc9bH1XDcwWQ9uFn5RWkOMbzMnk1qG-jVsZ5lX68_3l19yje3N5-vLje5LkUZ81a1NUokLMp66BQ20zTIBqUWHaGUQ9NVdYEjjdSimnTdUa0aQZWspErTWJ5l7w7e9NqPlULsFw6atltlyK6hF7Kqu0bWWCX0_IBqb0PwNPXO86L8ri-w3wfV74Pqj0El_M3RvA4Ljf_gv8kk4O0BsKv7v-oPi9WhuA</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Neumiller, Joshua J</creator><creator>Shubrook, Jay H</creator><creator>Manley, Tom</creator><creator>Alicic, Radica Z</creator><creator>Tuttle, Katherine R</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20220101</creationdate><title>Optimizing use of SGLT2 inhibitors and other evidence-based therapies to improve outcomes in patients with type 2 diabetes and chronic kidney disease: An opportunity for pharmacists</title><author>Neumiller, Joshua J ; Shubrook, Jay H ; Manley, Tom ; Alicic, Radica Z ; Tuttle, Katherine R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c323t-8a86050e0136b9a07ffb5705c29e055b794610dede80afc69e6a72e4545ac69d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Diabetes Mellitus, Type 2 - epidemiology</topic><topic>Humans</topic><topic>Pharmacists</topic><topic>Renal Insufficiency, Chronic - drug therapy</topic><topic>Renal Insufficiency, Chronic - epidemiology</topic><topic>Sodium-Glucose Transporter 2 Inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Neumiller, Joshua J</creatorcontrib><creatorcontrib>Shubrook, Jay H</creatorcontrib><creatorcontrib>Manley, Tom</creatorcontrib><creatorcontrib>Alicic, Radica Z</creatorcontrib><creatorcontrib>Tuttle, Katherine R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of health-system pharmacy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Neumiller, Joshua J</au><au>Shubrook, Jay H</au><au>Manley, Tom</au><au>Alicic, Radica Z</au><au>Tuttle, Katherine R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Optimizing use of SGLT2 inhibitors and other evidence-based therapies to improve outcomes in patients with type 2 diabetes and chronic kidney disease: An opportunity for pharmacists</atitle><jtitle>American journal of health-system pharmacy</jtitle><addtitle>Am J Health Syst Pharm</addtitle><date>2022-01-01</date><risdate>2022</risdate><volume>79</volume><issue>1</issue><spage>e65</spage><epage>e70</epage><pages>e65-e70</pages><issn>1079-2082</issn><eissn>1535-2900</eissn><cop>US</cop><pub>Oxford University Press</pub><pmid>34185826</pmid><doi>10.1093/ajhp/zxab271</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1079-2082 |
| ispartof | American journal of health-system pharmacy, 2022-01, Vol.79 (1), p.e65-e70 |
| issn | 1079-2082 1535-2900 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2546975604 |
| source | MEDLINE; Oxford University Press Journals All Titles (1996-Current) |
| subjects | Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - epidemiology Humans Pharmacists Renal Insufficiency, Chronic - drug therapy Renal Insufficiency, Chronic - epidemiology Sodium-Glucose Transporter 2 Inhibitors |
| title | Optimizing use of SGLT2 inhibitors and other evidence-based therapies to improve outcomes in patients with type 2 diabetes and chronic kidney disease: An opportunity for pharmacists |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-05T03%3A21%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Optimizing%20use%20of%20SGLT2%20inhibitors%20and%20other%20evidence-based%20therapies%20to%20improve%20outcomes%20in%20patients%20with%20type%202%20diabetes%20and%20chronic%20kidney%20disease:%20An%20opportunity%20for%20pharmacists&rft.jtitle=American%20journal%20of%20health-system%20pharmacy&rft.au=Neumiller,%20Joshua%20J&rft.date=2022-01-01&rft.volume=79&rft.issue=1&rft.spage=e65&rft.epage=e70&rft.pages=e65-e70&rft.issn=1079-2082&rft.eissn=1535-2900&rft_id=info:doi/10.1093/ajhp/zxab271&rft_dat=%3Cproquest_cross%3E2546975604%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2546975604&rft_id=info:pmid/34185826&rft_oup_id=10.1093/ajhp/zxab271&rfr_iscdi=true |